Scynexis (SCYX) Net Margin (2013 - 2025)

Scynexis (SCYX) posted Net Margin of 65.74% for Q4 2025, up 102.56% on a QoQ basis from 2572.16% in Q3 2025, and up 52449.0% year-over-year from N/an in Q4 2024.

Scynexis (SCYX) Net Margin (2013 - 2025) Analysis & Trends

Scynexis' Net Margin history runs 11 years deep, the most recent figure standing at 65.74% for Q4 2025.

  • Quarterly Net Margin rose 52449.0% year-over-year to 65.74% in Q4 2025, while the trailing twelve-month figure through Mar 2026 was 96.57% (up 93533.0% YoY) and the FY2025 annual result came in at 41.79%, up 52781.0% from the prior year.
  • Net Margin was 65.74% for Q4 2025 at Scynexis, up from 2572.16% in the prior quarter.
  • Across five years, Net Margin topped out at 93.01% in Q2 2023 and bottomed at 4904.02% in Q4 2021.
  • A 5-year average of 1122.42% and a median of 504.77% in 2025 frame the typical range for Net Margin.
  • Annual changes were most pronounced in 2022 — Net Margin surged 362456 bps — and 2023, when it tumbled 221916 bps.
  • Scynexis' Net Margin stood at 4904.02% in 2021, then soared by 74 bps to 1279.46% in 2022, then jumped by 71 bps to 366.84% in 2023, then slipped by 25 bps to 458.75% in 2024, then surged by 114 bps to 65.74% in 2025.
  • Business Quant data shows SCYX's Net Margin at 65.74% in Q4 2025, 2572.16% in Q3 2025, and 504.77% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 9.29%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 26.57%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -33.66%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 35.18%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 5.03%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 24.30%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 4.16%
10 Scynexis 21.55 Mn -15.20 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 65.74%
Sep 30, 2025 -2,572.16%
Jun 30, 2025 -504.77%
Mar 31, 2025 -2,097.67%
Dec 31, 2024 -458.75%
Sep 30, 2024 -425.45%
Jun 30, 2024 -1,964.40%
Mar 31, 2024 29.93%
Dec 31, 2023 -366.84%
Sep 30, 2023 -99.77%
Jun 30, 2023 93.01%
Mar 31, 2023 -2,997.88%
Dec 31, 2022 -1,279.46%
Sep 30, 2022 -1,900.06%
Jun 30, 2022 -1,008.69%
Mar 31, 2022 -778.71%
Dec 31, 2021 -4,904.02%
Sep 30, 2021 -117.25%
Mar 31, 2021 -38.80%
Jun 30, 2019 -14,742.11%